Skip to search formSkip to main contentSkip to account menu

BIM 26226

Known as: BIM-26226, BIM26226 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

BombesinPeptide Fragments
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Regulation of gastric function by gastrin releasing peptide
Hildebrand et al reported data suggesting that gastrin releasing peptide (GRP) may be a physiological regulator of pre- and… 
2000
2000
Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit in humans
1998
1998
Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma.
1996
1996
Mechanisms of bombesin on growth of gastrinoma (PT)in vivo
The growth of the human gastrinoma model (PT) in athymic nude mice is stimulated by bombesin (BBS), an amphibian peptide… 
1996
1996
Importance of gastrin-releasing peptide on acid-induced secretin release and pancreaticobiliary and duodenal bicarbonate secretion.
BACKGROUND Exogenous gastrin-releasing peptide (GRP) stimulates the release of secretin from the small intestine and… 
1995
1995
In-vivo effect of somatostatin analog, lanreotide, and/or grp antagonist, bim-26226, on the growth of colon-cancer peritoneal carcinomatosis in the rat.
The effect of somatostatin analogue, lanreotide, and bombesin/GRP antagonist, BIM 26226, on the growth of colon cancer peritoneal… 
1994
1994
Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)